[HTML][HTML] Molecular mechanisms and therapeutic targets for diabetic kidney disease
Diabetic kidney disease has a high global disease burden and substantially increases the
risk of kidney failure and cardiovascular events. Despite treatment, there is substantial …
risk of kidney failure and cardiovascular events. Despite treatment, there is substantial …
Obesity I: Overview and molecular and biochemical mechanisms
Obesity is a chronic, relapsing condition characterized by excess body fat. Its prevalence
has increased globally since the 1970s, and the number of obese and overweight people is …
has increased globally since the 1970s, and the number of obese and overweight people is …
Microgreens—A comprehensive review of bioactive molecules and health benefits
M Bhaswant, DK Shanmugam, T Miyazawa, C Abe… - Molecules, 2023 - mdpi.com
Microgreens, a hypothesized term used for the emerging food product that is developed from
various commercial food crops, such as vegetables, grains, and herbs, consist of developed …
various commercial food crops, such as vegetables, grains, and herbs, consist of developed …
METTL14 is required for exercise-induced cardiac hypertrophy and protects against myocardial ischemia-reperfusion injury
L Wang, J Wang, P Yu, J Feng, G Xu, X Zhao… - Nature …, 2022 - nature.com
RNA m6A modification is the most widely distributed RNA methylation and is closely related
to various pathophysiological processes. Although the benefit of regular exercise on the …
to various pathophysiological processes. Although the benefit of regular exercise on the …
Effect of calorie-unrestricted low-carbohydrate, high-fat diet versus high-carbohydrate, low-fat diet on type 2 diabetes and nonalcoholic fatty liver disease: a …
CD Hansen, EM Gram-Kampmann… - Annals of Internal …, 2023 - acpjournals.org
Background: It remains unclear if a low-carbohydrate, high-fat (LCHF) diet is a possible
treatment strategy for type 2 diabetes mellitus (T2DM), and the effect on nonalcoholic fatty …
treatment strategy for type 2 diabetes mellitus (T2DM), and the effect on nonalcoholic fatty …
Gut microbiota: A new target for T2DM prevention and treatment
L Liu, J Zhang, Y Cheng, M Zhu, Z Xiao… - Frontiers in …, 2022 - frontiersin.org
Type 2 diabetes mellitus (T2DM), one of the fastest growing metabolic diseases, has been
characterized by metabolic disorders including hyperglycemia, hyperlipidemia and insulin …
characterized by metabolic disorders including hyperglycemia, hyperlipidemia and insulin …
Plasma metabolite profiles related to plant-based diets and the risk of type 2 diabetes
F Wang, MY Baden, M Guasch-Ferré, C Wittenbecher… - Diabetologia, 2022 - Springer
Aims/hypothesis Plant-based diets, especially when rich in healthy plant foods, have been
associated with a lower risk of type 2 diabetes. However, whether plasma metabolite profiles …
associated with a lower risk of type 2 diabetes. However, whether plasma metabolite profiles …
[HTML][HTML] Management of diabesity: Current concepts
M Michaelidou, JM Pappachan… - World Journal of …, 2023 - ncbi.nlm.nih.gov
The global prevalence of obesity is increasing rapidly with an exponential rise in incidence
of type 2 diabetes mellitus in recent years.'Diabesity', the term coined to show the strong …
of type 2 diabetes mellitus in recent years.'Diabesity', the term coined to show the strong …
[HTML][HTML] Pathophysiology of obesity and its associated diseases
The occurrence of obesity has increased across the whole world. Many epidemiological
studies have indicated that obesity strongly contributes to the development of cancer …
studies have indicated that obesity strongly contributes to the development of cancer …
Bioinspired pH-Responsive Microalgal Hydrogels for Oral Insulin Delivery with Both Hypoglycemic and Insulin Sensitizing Effects
C Ren, D Zhong, Y Qi, C Liu, X Liu, S Chen, S Yan… - ACS …, 2023 - ACS Publications
The oral form of insulin is more convenient and has better patient compliance than
subcutaneous or intravenous insulin. Current oral insulin preparations, however, cannot …
subcutaneous or intravenous insulin. Current oral insulin preparations, however, cannot …